-

DMRC INVESTOR ALERT: Kirby McInerney LLP Notifies Digimarc Corporation Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of the July 8, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired Digimarc Corporation (“Digimarc” or the “Company”) (NASDAQ:DMRC) securities during the period from May 3, 2024, through February 26, 2025 (“the Class Period”).

[LEARN MORE ABOUT THE CLASS ACTION]

On February 26, 2025, Digimarc announced its financial results for the fourth quarter and the full year of 2024. The Company reported a 10% drop in quarterly subscription revenue, down to $5.0 million from $5.6 million the previous year, and a decrease in annual recurring revenue to $20.0 million from $22.23 million the prior year. These declines “primarily reflect[ed] a $5.8 million decrease in ARR due to the expiration of a commercial contract in June 2024.” On this news, the price of Digimarc shares declined by $11.65 per share, or approximately 43%, from $27.04 per share on February 26, 2025, to close at $15.39 on February 27, 2025.

The complaint alleges that defendants, throughout the Class Period, failed to disclose that: (1) that a large commercial partner would not renew a large contract on the same terms; (2) that, as a result, Digimarc would renegotiate the large commercial contract; and (3) that, as a result of the foregoing, the Company’s subscription revenue and annual recurring revenue would be adversely affected.

If you purchased or otherwise acquired Digimarc securities, have information, or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the form below, to discuss your rights or interests with respect to these matters without any cost to you.

[CONTACT FORM]

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

Kirby McInerney LLP

NASDAQ:DMRC

Release Versions
$Cashtags

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

More News From Kirby McInerney LLP

INVESTOR ALERT: Securities Class Action Filed Against Richtech Robotics Inc. – Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Richtech Robotics Inc. (“Richtech” or the “Company”) (NASDAQ:RR) securities during the period of January 27, 2026 through January 29, 2026, inclusive (“the Class Period”). If you suffered a loss on your Richtech investments, you have until April 3, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications sub...

INVESTOR ALERT: Securities Class Action Filed Against Ramaco Resources, Inc. – Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Ramaco Resources, Inc. (“Ramaco” or the “Company”) (NASDAQ:METC) securities during the period of July 31, 2025 through October 23, 2025, inclusive (“the Class Period”). If you suffered a loss on your Ramaco investments, you have until March 31, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications submitt...

REMINDER: Ardent Health, Inc. Investors With Significant Losses Must Act By March 9, 2026

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE:ARDT) investors of the March 9, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead p...
Back to Newsroom